Helios Klinikum Erfurt GmbH — Clinical Trial Site

57 Registered trials

27 Currently recruiting

Organisation

Helios Klinikum Erfurt GmbH

Location

Erfurt, Germany

Identifier

ORG-100025267

Address

Nordhaeuser Strasse 74, Andreasvorstadt, 99089, Germany

Departments

#4908: Dermatology
3. Medizinische Klinik
3. Medizinische Klinik, Kardiologie
4. Medizinische Klinik
7106:Abteilung fuer Neurologie
Abteilung für Urologie
Allgemeine und Inverventionelle Kardiologie
Cardiology
Department of Neurosurgery
Dermatologie und Allergologie
Dermatology and Allergology
Hauttumorzentrum Erfurt
I. Mediznische Klinik
Internal Medicine and Cardiology#2102
Kinderonkologisches Zentrum, Klinik für Kinder- und Jugendmedizin
Klinik fuer Pneumologie, Schlaf- und Beatmungsmedizin
Klinik für Hämatologie und internistische Onkologie, Stammzelltransplantation, Hämostaseologie
Klinik für Hautkrankheiten und Allergologie
Klinik für Kinder- und Jugendmedizin
Klinik für Kinder- und Jugendmedizin Päd. Onkologie / Hämatologie
Klinik für Kinder- und Jugendmedizin, Päd. Hämatologie und Onkologie
Klinik für Neurochirurgie
Klinik für Neurologie
Klinik für Pneumologie, Schlaf und Beatmungsmedizin
Klinik für Pneumologie, Schlaf- und Beatmungsmedizin
Klinik für Strahlentherapie
Klinik für Urologie
N/A
Neonatology
Neuroradiologie
Oncology for pediatrics
Päd. Onkologie / Hämatologie
Pädiatrische Hämatologie und Onkologie
Paedriatrics, Department of Oncology and Hematology
Pediatric hematology and oncology
Pediatric Hematology/Oncology
Pulmonology
Thoraxzentrum
Universitärer Campus Health and Medical University Erfurt 3. Medizinische Klinik
Zentrum für Kinder- und Jugendmedizin

Clinical trials at this site (57)

Search interface

International Euro Ewing (iEuroEwing) trial for treatment optimisation in patients with Ewing sarcoma Recruiting

2022-501180-40-00 Ewing Sarcoma 5 2022-06-17
Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy (MecMeth/ NOA-24) Recruiting

2024-511264-89-00 Glioblastoma 4 2022-04-11
SIOP-HRMB: An international prospective trial on clinically high-risk medulloblastoma (HR-MB) in patients older than 3 years. Recruiting

2024-510578-25-00 Histologically proven high-risk medulloblastoma, with a 5 2021-11-05
International study for children and adolescents with standard risk ALK-positive anaplastic large cell lymphoma (ALCL) estimating the effica… Recruiting

2022-501454-11-00 standard risk ALK-positive anaplastic large cell lympho 5 2020-02-05
SIOP RANDOMET 2017 Recruiting

2023-508926-91-00 Stage IV childhood renal tumour with pulmonary +/- non- 5 2019-12-05
LBL 2018 - International cooperative treatment protocol for children and adolescents with lymphoblastic lymphoma Recruiting

2023-508101-24-00 Lymphoblastic lymphoma 5 2019-08-01
SIOP Ependymoma II: An International Clinical Program for the diagnosis and treatment of children, adolescents and young adults with ependym… Recruiting

2024-512222-28-00 Newly diagnosed with an intracranial or spinal ependymo 10 2015-06-02
Phase III Clinical Trial for CPX-351 in Myeloid Leukemia in Children with Down Syndrome 2018 Ended

2022-501457-37-00 Myeloid Leukemia in Children with Down Syndrome 5 2024-10-28
ARTEMIS - A research study to look at how ziltivekimab works compared to placebo in people who have had a heart attack Ended

2023-506876-28-00 The medical condition we are investigating is type 1 AM 5 2024-08-01
A trial to see if the combination of fianlimab with cemiplimab works better than pembrolizumab for preventing or delaying melanoma from com… Ended

2022-501576-25-00 Melanoma 5 2023-07-07
A randomised, phase 3 trial comparing 3-weekly docetaxel 75 mg/m2 versus 2-weekly Docetaxel 50 mg/m2 in combination with Darolutamide + ADT … Ended

2022-502634-52-00 prostate cancer 5 2023-05-16
Clinical Study of Fianlimab in Combination With Cemiplimab versus Pembrolizumab in Adolescent and Adult Patients With Previously Untreated U… Ended

2023-505772-30-00 Melanoma 5 2022-11-09
A Global Study to Assess the Effects of Durvalumab with Oleclumab or Durvalumab with Monalizumab Following Concurrent Chemoradiation in Pati… Ended

2023-503999-24-00 Patients With Locally Advanced (Stage III), Unresectabl 5 2022-06-01
A study in patients with skin cancer Ended

2024-516914-39-00 Metastatic or unresectable melanoma 5 2022-04-27
The STARBOARD Study: Phase 3 Study of Encorafenib and Binimetinib Plus Pembrolizumab in BRAF V600E/K Mutation-Positive Metastatic or Unresec… Ended

2024-512038-13-00 Metastatic or unresectable locally advanced BRAF V600E/ 5 2021-09-16
Phase 3 Study of Belzutifan in Combination With Lenvatinib Versus Cabozantinib for Treatment of RCC Ended

2024-510620-39-00 Advanced RCC with clear cell component 5 2021-04-19
A study on the efficacy and safety of cisplatin/etoposide and concomitant radiotherapy in combination with durvalumab, an immunotherapy, in … Ended

2024-513433-20-00 Limited Disease Small Cell Lung Cancer 4 2020-12-16
Adjuvant nivolumab treatment in stage II high-risk melanoma – A randomized, controlled, phase III trial with biomarker-based risk stratifica… Ended

2023-509394-23-00 Stage II melanoma arising from a primary cutaneous site 5 2020-06-12
Comparison of Carboplatin and Cisplatin in patients with extracranial malignant germ cell tumours Ended

2023-507582-25-00 Malignant Extracranial Germ Cell Tumours (MGCT) 5 2019-08-02
AIEOP-BFM ALL 2017 - International collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia Ended

2023-509856-32-00 acute lymphoblastic leukemia in children and adolescent 5 2018-07-15
A trial funded by the German Federal Ministry for Education and Research (BMBF) to evaluate the effects of closed-loop automatic control of … Ended

2024-511335-10-01 Preterm infants with a gestational age (GA) at birth of 5 2018-07-01
A Study of Relatlimab plus Nivolumab Versus Nivolumab Alone in Participants with Advanced Melanoma Ended

2024-510913-13-00 Previously Untreated Metastatic or Unresectable Melanom 10 2018-05-18
International Study for Treatment of High Risk Childhood Relapsed ALL 2010 - A randomized Phase II Study Conducted by the Resistant Disease … Ended

2024-513070-21-00 Relapsed Acute Lymphoblastic Leukemia (ALL) 4 2018-02-15
International trial in Philadelphia chromosome-positive acute lymphoblastic leukemia Ended

2024-515499-12-00 Acute lymphoblastic leukemia 5 2017-10-02